Correlation Between Eupraxia Pharmaceuticals and Star Equity
Can any of the company-specific risk be diversified away by investing in both Eupraxia Pharmaceuticals and Star Equity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eupraxia Pharmaceuticals and Star Equity into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eupraxia Pharmaceuticals Common and Star Equity Holdings, you can compare the effects of market volatilities on Eupraxia Pharmaceuticals and Star Equity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eupraxia Pharmaceuticals with a short position of Star Equity. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eupraxia Pharmaceuticals and Star Equity.
Diversification Opportunities for Eupraxia Pharmaceuticals and Star Equity
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Eupraxia and Star is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Eupraxia Pharmaceuticals Commo and Star Equity Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Star Equity Holdings and Eupraxia Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eupraxia Pharmaceuticals Common are associated (or correlated) with Star Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Star Equity Holdings has no effect on the direction of Eupraxia Pharmaceuticals i.e., Eupraxia Pharmaceuticals and Star Equity go up and down completely randomly.
Pair Corralation between Eupraxia Pharmaceuticals and Star Equity
Given the investment horizon of 90 days Eupraxia Pharmaceuticals Common is expected to generate 1.42 times more return on investment than Star Equity. However, Eupraxia Pharmaceuticals is 1.42 times more volatile than Star Equity Holdings. It trades about 0.04 of its potential returns per unit of risk. Star Equity Holdings is currently generating about 0.02 per unit of risk. If you would invest 295.00 in Eupraxia Pharmaceuticals Common on August 28, 2024 and sell it today you would earn a total of 46.00 from holding Eupraxia Pharmaceuticals Common or generate 15.59% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 32.93% |
| Values | Daily Returns |
Eupraxia Pharmaceuticals Commo vs. Star Equity Holdings
Performance |
| Timeline |
| Eupraxia Pharmaceuticals |
| Star Equity Holdings |
Eupraxia Pharmaceuticals and Star Equity Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eupraxia Pharmaceuticals and Star Equity
The main advantage of trading using opposite Eupraxia Pharmaceuticals and Star Equity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eupraxia Pharmaceuticals position performs unexpectedly, Star Equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Star Equity will offset losses from the drop in Star Equity's long position.| Eupraxia Pharmaceuticals vs. Vivani Medical | Eupraxia Pharmaceuticals vs. Alpha Tau Medical | Eupraxia Pharmaceuticals vs. Dogwood Therapeutics, | Eupraxia Pharmaceuticals vs. Elicio Therapeutics |
| Star Equity vs. Star Equity Holdings | Star Equity vs. XOMA Corp | Star Equity vs. Fundamental Global | Star Equity vs. Fortress Biotech Pref |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |